"Salmeterol Xinafoate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
| Descriptor ID |
D000068299
|
| MeSH Number(s) |
D02.033.100.291.057.750 D02.092.063.291.057.750 D02.092.471.683.061.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Salmeterol Xinafoate".
Below are MeSH descriptors whose meaning is more specific than "Salmeterol Xinafoate".
This graph shows the total number of publications written about "Salmeterol Xinafoate" by people in this website by year, and whether "Salmeterol Xinafoate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Salmeterol Xinafoate" by people in Profiles.
-
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol. 2008 Dec; 122(6):1138-1144.e4.
-
Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J. 2001 Feb; 17(2):233-40.
-
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. Am J Physiol Lung Cell Mol Physiol. 2001 Feb; 280(2):L286-97.